Extensive use and growing demand for biologics come at a time when there is increasing need for savings and efficiencies within the health care systems. Biosimilar medicines may provide cost savings for patients who can benefit from biologic medicines. By potentially providing more affordable options, biosimilar medicines can allow for the reallocation of resources to other areas of patient care. In addition biosimilars could lead to earlier intervention with the appropriate biologic medicines, potentially improving treatment outcomes.
Changing the landscape
Potential cost savings from biosimilars to health care systems may be substantial
Cost savings
The potential to improve outcomes
Biosimilars may offer a number of potential benefits to various stakeholders
Potential of biosimilars for patients, payers, and providers
of biologics
Additional treatment choices at lower cost to the health care system
and outcomes
Increase access to biologics, which may lead to improved health outcomes overall
efficiency
Possible savings and efficiencies to the health care system
for patients
Offer a variety of therapeutic options
